US Bancorp’s CNO Financial Group CNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Sell
4,753
-1,073
-18% -$49.8K ﹤0.01% 2003
2026
Q1
$239K Sell
5,826
-34
-0.6% -$1.42K ﹤0.01% 1922
2025
Q4
$249K Buy
5,860
+101
+2% +$4.12K ﹤0.01% 1918
2025
Q3
$228K Buy
5,759
+1,682
+41% +$64.3K ﹤0.01% 1941
2025
Q2
$157K Buy
4,077
+272
+7% +$10.4K ﹤0.01% 2185
2025
Q1
$158K Hold
3,805
﹤0.01% 2143
2024
Q4
$142K Hold
3,805
﹤0.01% 2218
2024
Q3
$134K Buy
3,805
+45
+1% +$1.45K ﹤0.01% 2246
2024
Q2
$104K Sell
3,760
-9
-0.2% -$246 ﹤0.01% 2319
2024
Q1
$104K Sell
3,769
-31
-0.8% -$837 ﹤0.01% 2348
2023
Q4
$106K Sell
3,800
-305
-7% -$7.68K ﹤0.01% 2323
2023
Q3
$97.4K Sell
4,105
-20
-0.5% -$481 ﹤0.01% 2165
2023
Q2
$97.6K Sell
4,125
-423
-9% -$9.42K ﹤0.01% 2210
2023
Q1
$101K Buy
4,548
+469
+11% +$11.2K ﹤0.01% 2188
2022
Q4
$93.2K Buy
4,079
+917
+29% +$19.8K ﹤0.01% 2230
2022
Q3
$57K Sell
3,162
-2,671
-46% -$49.5K ﹤0.01% 2452
2022
Q2
$105K Buy
5,833
+934
+19% +$20K ﹤0.01% 2209
2022
Q1
$123K Buy
4,899
+46
+0.9% +$1.14K ﹤0.01% 2196
2021
Q4
$116K Sell
4,853
-9
-0.2% -$221 ﹤0.01% 2227
2021
Q3
$114K Sell
4,862
-58
-1% -$1.36K ﹤0.01% 2225
2021
Q2
$116K Buy
4,920
+67
+1% +$1.71K ﹤0.01% 2225
2021
Q1
$118K Sell
4,853
-652
-12% -$15.5K ﹤0.01% 2178
2020
Q4
$122K Buy
5,505
+481
+10% +$9.8K ﹤0.01% 2114
2020
Q3
$81K Sell
5,024
-7,960
-61% -$128K ﹤0.01% 2185
2020
Q2
$201K Sell
12,984
-4,490
-26% -$61.9K ﹤0.01% 1755
2020
Q1
$216K Sell
17,474
-1,175
-6% -$19.3K ﹤0.01% 1629
2019
Q4
$338K Buy
18,649
+6,010
+48% +$102K ﹤0.01% 1559
2019
Q3
$200K Buy
12,639
+171
+1% +$2.7K ﹤0.01% 1798
2019
Q2
$208K Sell
12,468
-1,673
-12% -$27.7K ﹤0.01% 1811
2019
Q1
$229K Buy
14,141
+1,883
+15% +$31.9K ﹤0.01% 1748
2018
Q4
$183K Buy
12,258
+573
+5% +$10.4K ﹤0.01% 1804
2018
Q3
$248K Buy
11,685
+2,722
+30% +$57.1K ﹤0.01% 1763
2018
Q2
$171K Sell
8,963
-1,967
-18% -$40.7K ﹤0.01% 1945
2018
Q1
$237K Buy
10,930
+45
+0.4% +$1.06K ﹤0.01% 1782
2017
Q4
$269K Sell
10,885
-3,516
-24% -$85.8K ﹤0.01% 1724
2017
Q3
$336K Sell
14,401
-2,669
-16% -$59.6K ﹤0.01% 1605
2017
Q2
$356K Sell
17,070
-2,804
-14% -$57.9K ﹤0.01% 1552
2017
Q1
$408K Sell
19,874
-145
-0.7% -$2.91K ﹤0.01% 1473
2016
Q4
$383K Buy
20,019
+399
+2% +$6.86K ﹤0.01% 1494
2016
Q3
$300K Sell
19,620
-33,157
-63% -$541K ﹤0.01% 1567
2016
Q2
$921K Sell
52,777
-15,969
-23% -$300K ﹤0.01% 1044
2016
Q1
$1.23M Sell
68,746
-8,245
-11% -$143K ﹤0.01% 879
2015
Q4
$1.47M Sell
76,991
-2,064
-3% -$40.1K 0.01% 802
2015
Q3
$1.49M Buy
79,055
+6,516
+9% +$118K 0.01% 788
2015
Q2
$1.33M Buy
72,539
+3,618
+5% +$65.6K 0.01% 874
2015
Q1
$1.19M Buy
68,921
+5,259
+8% +$86.7K ﹤0.01% 944
2014
Q4
$1.1M Sell
63,662
-339
-0.5% -$5.83K ﹤0.01% 963
2014
Q3
$1.09M Sell
64,001
-3,861
-6% -$66.5K ﹤0.01% 954
2014
Q2
$1.21M Buy
67,862
+3,653
+6% +$62.3K ﹤0.01% 911
2014
Q1
$1.16M Buy
64,209
+11,200
+21% +$201K ﹤0.01% 898
2013
Q4
$938K Sell
53,009
-4,953
-9% -$79.4K ﹤0.01% 957
2013
Q3
$835K Buy
57,962
+6,467
+13% +$92.2K ﹤0.01% 969
2013
Q2
$667K Buy
+51,495
New +$609K ﹤0.01% 1018

Other funds holding CNO

US Bancorp's CNO Position: Q2 2026 in Review

US Bancorp reduced its CNO Financial Group (CNO) stake by 18% in Q2 2026, selling an estimated $49.8K and leaving 4,753 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

US Bancorp first reported a position in CNO in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.49M in Q3 2015. 383 funds tracked by Wall St. Rank hold CNO as of Q2 2026.

  • US Bancorp held 4,753 shares of CNO Financial Group worth $242K as of Q2 2026.
  • US Bancorp sold 1,073 CNO Financial Group shares in Q2 2026, an estimated $49.8K.
  • CNO Financial Group made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2003 holding.
  • US Bancorp first reported a position in CNO Financial Group in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's CNO Financial Group position peaked at $1.49M in Q3 2015.
  • 383 funds tracked by Wall St. Rank held CNO Financial Group as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.